Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide

Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide

Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of Sputtering Power on the Microstructure and Tribological Properties of TiN/TiAlN Coatings Prepared by DC Magnetron Sputtering.

Materials (Basel, Switzerland)·2026

Same author

Hydrogen radical is also a critical reductive defluorination species in the Far-UVC-activated sulfite process.

Journal of hazardous materials·2026

Same author

COF@DNAzyme Empowering Endogenous Copper for One-Stitch Bioorthogonal Catalysis-Based Anticancer Therapy.

Angewandte Chemie (International ed. in English)·2026

Same author

Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

JCO precision oncology·2026

Same author

Enhancing Volumetric Imaging in Linear-Array Photoacoustic Tomography: multiview fusion with deep learning.

IEEE transactions on bio-medical engineering·2026

Same author

Motion prediction for leader manipulator of teleoperation system with large time delay based on inverse optimal control.

ISA transactions·2026

Search research articles

Related Experiment Video

Updated: Jun 18, 2025

High Resolution Physical Characterization of Single Metallic Nanoparticles

High Resolution Physical Characterization of Single Metallic Nanoparticles

Published on: June 28, 2019

Polyoxometalates: metallodrug agents for combating amyloid aggregation.

Mengmeng Ma^1,2, Zhenqi Liu^1,2, Huisi Zhao^1,2

¹Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.

National Science Review

|July 31, 2024

Summary

Polyoxometalates (POMs) show promise in preventing amyloid-beta plaque buildup, a key factor in Alzheimer's disease (AD). Research explores POM structures to enhance their effectiveness against AD pathogenesis.

Keywords:

Alzheimer's disease amyloid inhibition amyloid-β metallodrug polyoxometalate

More Related Videos

Preparation of Polyoxometalate-based Photo-responsive Membranes for the Photo-activation of Manganese Oxide Catalysts

Preparation of Polyoxometalate-based Photo-responsive Membranes for the Photo-activation of Manganese Oxide Catalysts

Published on: August 7, 2018

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

Related Experiment Videos

Last Updated: Jun 18, 2025

High Resolution Physical Characterization of Single Metallic Nanoparticles

High Resolution Physical Characterization of Single Metallic Nanoparticles

Published on: June 28, 2019

Preparation of Polyoxometalate-based Photo-responsive Membranes for the Photo-activation of Manganese Oxide Catalysts

Preparation of Polyoxometalate-based Photo-responsive Membranes for the Photo-activation of Manganese Oxide Catalysts

Published on: August 7, 2018

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

Area of Science:

Neuroscience
Materials Science
Medicinal Chemistry

Background:

Alzheimer's disease (AD) affects millions globally, characterized by amyloid-beta (Aβ) plaque accumulation.
Aβ plaques are a primary pathological hallmark and a significant therapeutic target for AD.
Polyoxometalates (POMs) are emerging as potential modulators of Aβ aggregation.

Purpose of the Study:

To review recent advancements in utilizing POMs for mitigating amyloidosis in Alzheimer's disease.
To establish correlations between the structural characteristics of POMs and their anti-amyloid activities.
To discuss the future potential and challenges of POMs in Alzheimer's disease therapy.

Main Methods:

Review of current literature on Polyoxometalates (POMs) and their application in Alzheimer's disease research.
Analysis of structure-activity relationships between POMs and amyloid-beta (Aβ) aggregation.
Discussion of the physicochemical properties of POMs (charge, polarity, structure) relevant to Aβ interaction.

Main Results:

POMs exhibit significant potential in modulating Aβ aggregation due to their unique structural and electronic properties.
Specific structural features of POMs are directly correlated with their efficacy in inhibiting amyloid formation.
POMs offer a tunable platform for developing novel therapeutic strategies against Alzheimer's disease.

Conclusions:

POMs represent a promising class of compounds for developing new treatments for Alzheimer's disease.
Further research into POM structure-activity relationships is crucial for optimizing their therapeutic potential.
Addressing current challenges will pave the way for the clinical application of POMs in combating AD.